The Best Longevity Blood Tests and Panels in Ireland (2026)

The idea that you can feel perfectly healthy while harbouring silent metabolic dysfunction is one of the most important lessons in longevity medicine. Heart disease, type 2 diabetes, and many cancers develop over decades before they produce symptoms, and by the time you notice something is wrong, significant damage has often already occurred. Blood testing offers a window into these processes years or even decades before clinical disease manifests, allowing you to intervene when the trajectory is still easily reversible.

A landmark 2024 study published in Geroscience tracked 1,224 centenarians and 3,672 matched non-centenarians over 35 years. The researchers found that individuals who reached 100 showed more favourable biomarker values from age 65 onwards, including lower glucose, creatinine, and uric acid, lower liver enzymes, and interestingly, higher total cholesterol and iron than those who did not reach exceptional old age. The study did not claim that any single marker was a reliable predictor of longevity on its own, but it reinforced a powerful idea: the biological patterns associated with a long life are measurable in the blood, and they are measurable early enough to act upon.

For people in Ireland, this raises a practical question. The standard blood panel your GP might order during an annual check-up - a full blood count, basic liver and kidney function, fasting glucose, and perhaps a lipid profile - is a reasonable starting point but captures only a fraction of the picture. A true longevity blood panel goes considerably deeper, examining metabolic health, cardiovascular risk, inflammation, hormonal balance, and nutrient status with a specificity that the standard panel simply does not offer. Understanding which tests to request, where to get them, and what the results actually mean is one of the most valuable investments you can make in your long-term health.

Metabolic dysfunction is arguably the single greatest driver of chronic disease and accelerated ageing, and it is also one of the most modifiable. The standard approach in Irish general practice is to measure fasting glucose and, if that is elevated, to check HbA1c. This catches overt diabetes and clear prediabetes, but it misses the earlier stages of metabolic dysfunction where intervention is most effective. A longevity-focused metabolic panel adds several crucial markers that reveal problems years before glucose begins to rise.

Fasting insulin is perhaps the most underutilised marker in mainstream medicine. Insulin resistance - the state where your cells become less responsive to insulin, forcing your pancreas to produce ever more of it to maintain normal blood sugar - can persist for a decade or longer before fasting glucose begins to climb. By measuring fasting insulin alongside fasting glucose, you can calculate the HOMA-IR score, a simple index of insulin resistance. A HOMA-IR below 1.0 is considered optimal by most longevity-focused practitioners, though values below 1.5 are generally reassuring. Most Irish GPs will not order fasting insulin as a matter of routine, so you may need to request it specifically or seek it through a functional medicine practitioner.

HbA1c provides a three-month average of blood sugar levels and is the standard diagnostic tool for diabetes. For longevity purposes, most practitioners aim for an HbA1c well below the diabetic threshold of 48 mmol/mol, with an optimal range of 28 to 36 mmol/mol. Uric acid is another metabolic marker gaining attention in the longevity community. Once considered relevant only in the context of gout, elevated uric acid is now recognised as an independent risk factor for cardiovascular disease, kidney disease, and metabolic syndrome. An optimal level for longevity sits below 360 micromol/L for men and 300 for women. Together, these markers - fasting glucose, fasting insulin, HOMA-IR, HbA1c, and uric acid - provide a far more complete picture of metabolic health than glucose alone.

Standard lipid panels in Ireland report total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. This information is useful but incomplete. Over the past decade, the understanding of cardiovascular risk has shifted dramatically, and the markers that matter most for predicting heart disease are not the ones that appear on a standard lipid panel. For anyone serious about longevity, three additional markers deserve attention: apolipoprotein B, lipoprotein(a), and the triglyceride-to-HDL ratio.

Apolipoprotein B, commonly written as ApoB, is a protein found on every atherogenic lipoprotein particle - the particles that actually penetrate your arterial walls and cause plaque to build up. Unlike LDL cholesterol, which measures the cholesterol content carried by LDL particles, ApoB tells you how many atherogenic particles are circulating. Two people can have identical LDL cholesterol levels but wildly different ApoB counts, and it is the particle number that drives risk. Most longevity practitioners consider an ApoB below 80 mg/dL desirable, with below 60 mg/dL considered optimal for those at higher risk. ApoB is not routinely included in Irish GP blood panels, but it can be ordered through private laboratories such as Affidea, Beacon Hospital, and RandoxHealth.

Lipoprotein(a), abbreviated as Lp(a), is a genetically determined lipoprotein that significantly increases cardiovascular risk when elevated. Unlike most blood markers, Lp(a) levels are largely fixed by your genetics and do not respond meaningfully to diet or lifestyle changes. This makes it a one-time test: once you know your Lp(a) level, there is no need to recheck it. Approximately 20 per cent of the population has elevated Lp(a), and knowing your status allows you to manage other risk factors more aggressively if needed. The triglyceride-to-HDL ratio, meanwhile, is a simple calculation you can derive from a standard lipid panel. A ratio below 1.5 (using mmol/L units) is considered a strong marker of metabolic health and low cardiovascular risk, while a ratio above 2.5 suggests insulin resistance and elevated atherogenic particle counts, even when LDL cholesterol looks normal.

Chronic low-grade inflammation is increasingly recognised as a central driver of ageing and age-related disease. Unlike the acute inflammation that occurs when you cut your finger or catch a cold, chronic systemic inflammation operates quietly in the background, accelerating atherosclerosis, promoting insulin resistance, damaging joints, and increasing cancer risk. Two blood markers - high-sensitivity C-reactive protein and homocysteine - offer valuable insight into this process.

High-sensitivity CRP, written as hs-CRP, is a general marker of systemic inflammation. It is not specific enough to diagnose any particular condition, but that is precisely what makes it useful as a longevity marker. An hs-CRP below 1.0 mg/L is considered low risk and optimal. Values between 1.0 and 3.0 mg/L suggest moderate systemic inflammation, while readings above 3.0 mg/L indicate elevated inflammation that warrants investigation into potential causes such as visceral adiposity, periodontal disease, chronic infection, poor sleep, or autoimmune activity. A single elevated reading should be confirmed with a repeat test, as transient illness or injury can temporarily spike the result. Most GPs in Ireland can order hs-CRP without difficulty, making it one of the more accessible longevity markers.

Homocysteine is an amino acid whose elevation in the blood is associated with increased cardiovascular risk, cognitive decline, and bone fractures. Optimal levels sit below 8 micromol/L, though the conventional reference range extends much higher. Elevated homocysteine often reflects inadequate intake or poor metabolism of B vitamins, particularly B12, folate, and B6. This makes it both a risk marker and a clue to potential nutritional deficiencies. In Ireland, where vitamin B12 deficiency is more common than many people realise - particularly among older adults and those on proton pump inhibitors or metformin - checking homocysteine alongside B12 and folate provides a more complete picture of methylation health than any single marker alone.

Hormonal decline is one of the most tangible aspects of ageing, and it is also one of the areas where a standard GP blood panel is most likely to miss meaningful dysfunction. The typical approach in Irish general practice is to test thyroid-stimulating hormone and, if that is abnormal, to investigate further. For longevity purposes, a full thyroid panel - TSH, free T3, free T4, and thyroid antibodies - provides a far more nuanced picture. TSH alone can miss subclinical hypothyroidism, poor T4-to-T3 conversion, and early autoimmune thyroid disease, all of which affect energy, metabolism, mood, and long-term health.

Sex hormones represent another area where conventional and longevity-focused approaches diverge considerably. For men, the standard approach is to check total testosterone only when symptoms of deficiency are obvious. A longevity panel adds free testosterone, sex hormone-binding globulin, and DHEA-sulphate. Total testosterone can sit within the broad reference range while free testosterone - the biologically active fraction - is meaningfully low, particularly in men over 40 whose SHBG levels tend to rise with age. DHEA-S, produced by the adrenal glands, is sometimes described as a marker of biological age because it declines predictably from the mid-twenties onwards and is associated with immune function, bone density, and cardiovascular health.

For women, a comprehensive hormone panel becomes particularly important during the perimenopausal years, typically beginning in the early to mid-forties. Oestrogen, progesterone, testosterone, and DHEA-S all shift during this transition, and tracking these changes allows for earlier and more targeted intervention if hormone replacement therapy is being considered. In Ireland, most GPs will order basic thyroid function and, when indicated, sex hormones. However, the full panel described here - including free T3, SHBG, DHEA-S, and detailed sex hormone profiles - is more readily available through functional medicine practitioners or private laboratories.

Ireland's northerly latitude and famously overcast skies make vitamin D deficiency remarkably common. Studies consistently show that a large proportion of the Irish population has suboptimal vitamin D levels, particularly during the winter months from October to March. For longevity, most practitioners target a 25-hydroxyvitamin D level of 100 to 150 nmol/L, considerably higher than the conventional sufficiency threshold of 50 nmol/L. Vitamin D influences immune function, bone health, mood, muscle function, and cardiovascular risk, making it one of the most important and most affordable markers to monitor. Your GP can order this test routinely, and supplementation is straightforward and inexpensive.

Magnesium is an essential mineral involved in over 300 enzymatic reactions in the body, yet it is one of the most commonly deficient micronutrients in Western diets. The standard serum magnesium test offered by most laboratories is a poor indicator of true magnesium status because only about one per cent of the body's magnesium resides in the blood. Red blood cell magnesium, or RBC magnesium, provides a much more accurate assessment of intracellular magnesium stores. Unfortunately, RBC magnesium is not available through most standard Irish GP panels and typically requires a private or functional medicine laboratory. Given magnesium's role in sleep quality, blood pressure regulation, insulin sensitivity, and muscle function, it is a worthwhile addition to any longevity panel.

Ferritin, B12, and folate are standard markers that most GPs include in routine blood work, but their interpretation differs in a longevity context. Ferritin reflects iron stores and is relevant to both deficiency and excess. While low ferritin causes fatigue and impaired exercise capacity, elevated ferritin is associated with increased oxidative stress, inflammation, and cardiovascular risk. An optimal longevity range sits between 40 and 150 micrograms per litre for most adults. The omega-3 index, which measures the proportion of EPA and DHA in red blood cell membranes, is a newer marker that reflects long-term omega-3 fatty acid intake. An index above 8 per cent is associated with reduced cardiovascular risk and improved cognitive outcomes, while most people in Ireland test below 5 per cent. The omega-3 index is available through private laboratories and some functional medicine clinics.

The standard organ function markers that appear on a routine GP blood panel are genuinely important for longevity, though they are sometimes overlooked in the rush to discuss more exotic tests. Liver enzymes - ALT, AST, and GGT - reflect the health of the liver, the body's central metabolic organ. For longevity, you want these enzymes sitting comfortably within the lower half of the reference range. Mildly elevated liver enzymes, even when technically within the normal range, can signal early fatty liver disease, excessive alcohol intake, or metabolic dysfunction. GGT in particular has emerged as an independent predictor of cardiovascular disease and all-cause mortality in several large studies.

Kidney function, assessed through creatinine and the estimated glomerular filtration rate, is another marker that deserves more attention than it typically receives. The centenarian study in Geroscience found that those who reached 100 had lower creatinine levels from age 65 onwards, suggesting that preserved kidney function is an important component of exceptional longevity. An eGFR above 90 mL/min indicates normal kidney function, while values between 60 and 89 may warrant monitoring and investigation of potential contributing factors such as hypertension, diabetes, or chronic NSAID use.

The full blood count remains one of the most information-dense tests in medicine, providing data on red blood cells, white blood cells, platelets, haemoglobin, and several derived indices. For longevity purposes, particular attention should be paid to haemoglobin levels, mean corpuscular volume, and white blood cell count. A low white blood cell count within the normal range is generally considered favourable from a longevity perspective, as it may reflect lower systemic inflammation. Conversely, a persistently elevated white cell count, even when technically normal, can signal chronic low-grade inflammation that deserves attention. These standard markers are readily available through any GP in Ireland and form the foundation upon which more specialised longevity testing is built.

The most straightforward route to blood testing in Ireland is through your GP. If you hold a medical card or GP visit card, blood tests ordered by your GP are free of charge. For private patients, the GP visit itself typically costs between €50 and €65, and most standard blood panels are processed through the hospital laboratory system at no additional charge to the patient. This route works well for basic panels including a full blood count, liver and kidney function, fasting glucose, HbA1c, lipids, thyroid function, vitamin D, B12, and ferritin. However, many of the advanced markers discussed in this article - particularly ApoB, Lp(a), fasting insulin, RBC magnesium, and the omega-3 index - are not routinely available through the standard GP pathway.

Private laboratories offer the next tier of access. Affidea operates multiple locations across Ireland and offers a range of health screening packages. Beacon Hospital in Dublin provides comprehensive blood panels, as does RandoxHealth, which has clinics in both Northern Ireland and Dublin. Pure Pharmacy offers walk-in blood testing with panels ranging from approximately €100 for a standard screen to €400 for a comprehensive longevity-style panel. Folacare is another option, with individual panels starting from around €25 and more comprehensive options running up to €300. These private services allow you to order specific markers without a GP referral, though it is worth considering that interpreting the results of an advanced longevity panel without professional guidance can be challenging.

Functional medicine practitioners represent the most comprehensive option for longevity blood testing. Clinics such as Integrative Medicine Dublin, the Dublin Centre for Functional Medicine, and PFoley Clinic are experienced in ordering and interpreting the full range of longevity markers, including the more specialised tests that fall outside standard laboratory menus. The advantage of this route is that you receive not just the results but also a detailed interpretation and an actionable plan based on your specific findings. The disadvantage is cost: a functional medicine consultation runs €150 to €600, plus the cost of the testing itself. For those willing to invest, this pathway provides the deepest insight into your biological health.

The question of testing frequency depends on the marker in question and your individual risk profile. For most longevity markers - metabolic panel, lipids, ApoB, inflammation markers, hormones, and nutrient levels - annual testing provides a reasonable balance between vigilance and practicality. Annual testing allows you to track trends over time, which is often more informative than any single result in isolation. A fasting glucose of 5.4 mmol/L is more concerning if it was 4.8 two years ago than if it has been stable at 5.3 for a decade. Trends reveal trajectory, and trajectory is what matters most for longevity.

There are important exceptions to the annual rule. Lp(a) is genetically determined and effectively fixed for life, so a single test is sufficient unless you are prescribed a therapy specifically targeting it. Conversely, if you make a significant intervention - starting a new medication, overhauling your diet, beginning a supplement protocol, or commencing hormone replacement therapy - it is reasonable to recheck relevant markers at three to six months to assess the impact. Vitamin D is worth checking twice yearly in Ireland, once at the end of winter when levels are typically lowest and once in late summer, until you establish a supplementation dose that keeps you consistently in the optimal range.

Interpreting your results requires understanding the difference between conventional reference ranges and optimal ranges. Laboratory reference ranges are typically derived from the middle 95 per cent of the tested population, which includes many people with subclinical disease. A result that falls within the reference range is not necessarily optimal for longevity. For example, a fasting glucose of 6.0 mmol/L is technically below the diabetic threshold but is far from ideal. Similarly, a TSH of 4.0 mIU/L sits within most laboratory reference ranges but would concern a longevity-focused practitioner. Working with a practitioner who understands optimal ranges and can contextualise your results within your full health picture is invaluable, particularly when you are establishing your baseline. Over time, as you become more familiar with your own patterns and the markers that matter most for your individual risk profile, you will develop an increasingly informed relationship with your own biology.